| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.014 | 0.9 |